Capricor Therapeutics Inc (CAPR)
EBITDA Growth
1817.57%
TTM · Period ending:
CAPR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported1817.57%period ending
Latest reported1817.57%period ending
CAPR TTM EBITDA YoY % (19.98% → 1817.57%)
Year-over-year change
High-resolution chart · PNG
CAPR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 1,817.5724% | |
| 1,767.7405% | |
| 2,412.2634% | |
| -144.9278% | |
| -156.2299% | |
| -131.4526% | |
| -83.9983% | |
| -15.7706% | |
| 6.1214% | |
| 18.219% | |
| 25.513% | |
| -4.5237% | |
| -15.025% | |
| -26.331% | |
| -43.9726% | |
| -51.9655% | |
| -38.5932% | |
| -35.086% | |
| -46.0643% | |
| -64.1973% | |
| -108.3288% | |
| -132.7959% | |
| -79.118% | |
| -16.161% | |
| 28.0152% | |
| 49.0691% | |
| 49.9956% | |
| -1,920.4678% | |
| -679.7561% | |
| -591.5993% | |
| -608.5407% | |
| 103.7101% | |
| 112.4688% | |
| 116.0824% | |
| 116.2194% | |
| 19.638% | |
| -10.946% | |
| -33.2487% | |
| -46.724% | |
| -55.009% | |
| -51.9742% | |
| -62.1991% | |
| -109.1898% | |
| 4.7619% | |
| 16.6468% | |
| 30.8684% | |
| 50.4956% | |
| -146.2417% | |
| -209.2749% | |
| -576.883% | |
| -984.8648% | |
| -83.8248% | |
| -20.0027% | |
| 60.7204% | |
| 77.1964% | |
| 39.5014% | |
| 35.9863% | |
| 19.6774% | |
| 22.3496% | |
| 37.3011% | |
| 29.3442% | |
| 30.2203% | |
| 18.6586% | |
| 25.7818% | |
| 33.6286% | |
| 32.9309% | |
| 41.8755% | |
| 29.7596% | |
| 26.6195% | |
| 0.5688% | |
| -40.2507% | |
| -92.081% | |
| -388.2062% | |
| -695.7802% | |
| -1,095.6176% | |
| -757.7708% | |
| -33,461.5482% | |
| -7,130.7076% | |
| -4,101.1187% | |
| -3,499.2804% | |
| 60.3694% | |
| 5.7364% | |
| 0.9661% | |
| -53.9978% | |
| -103.6034% | |
| -47.2679% | |
| -17.8673% | |
| 1.9395% | |
| 52.9844% | |
| 46.1377% | |
| 9.1277% | |
| 13.6528% | |
| -76.8593% | |
| -299.1783% | |
| 19.9775% |